UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
Inspire Medical Systems (NYSE: INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the Jefferies London Healthcare Conference. The presentation is scheduled for Wednesday, November 20, 2024, at 7:30 a.m. Eastern Time. Interested parties can access the presentation through a live webcast, with replays available for two weeks afterward on the company's investor website at investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), un'azienda di tecnologia medica specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, ha annunciato la sua partecipazione alla Conferenza Sanitaria di Jefferies a Londra. La presentazione è programmata per mercoledì 20 novembre 2024, alle 7:30 ora orientale. Le parti interessate possono accedere alla presentazione tramite un webcast dal vivo, con le registrazioni disponibili per due settimane successivamente sul sito web per investitori dell'azienda all'indirizzo investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), una empresa de tecnología médica especializada en soluciones mínimamente invasivas para la apnea obstructiva del sueño, ha anunciado su participación en la Conferencia de Salud de Jefferies en Londres. La presentación está programada para el miércoles 20 de noviembre de 2024, a las 7:30 a.m. hora del Este. Las partes interesadas pueden acceder a la presentación a través de una transmisión web en vivo, con repeticiones disponibles durante dos semanas después en el sitio web para inversores de la empresa en investors.inspiresleep.com.
인스파이어 메디컬 시스템즈 (NYSE: INSP)는 폐쇄성 수면 무호흡증을 위한 최소 침습 솔루션에 전문화된 의료 기술 회사로, 제퍼리스 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 발표는 2024년 11월 20일 수요일 오전 7시 30분 동부 표준시로 예정되어 있습니다. 관심 있는 분들은 생중계 웹캐스트를 통해 발표에 접근할 수 있으며, 발표 후 2주 동안 회사 투자자 웹사이트인 investors.inspiresleep.com에서 다시 볼 수 있습니다.
Inspire Medical Systems (NYSE: INSP), une entreprise de technologie médicale spécialisée dans les solutions mini-invasives pour l'apnée obstructive du sommeil, a annoncé sa participation à la Conférence de Santé Jefferies à Londres. La présentation est prévue pour le mercredi 20 novembre 2024, à 7h30, heure de l'Est. Les parties intéressées peuvent accéder à la présentation via un webinaire en direct, avec des rediffusions disponibles pendant deux semaines par la suite sur le site web pour investisseurs de l'entreprise à l'adresse investors.inspiresleep.com.
Inspire Medical Systems (NYSE: INSP), ein Medizintechnikunternehmen, das sich auf minimalinvasive Lösungen für obstruktive Schlafapnoe spezialisiert hat, hat seine Teilnahme an der Jefferies London Healthcare Conference angekündigt. Die Präsentation ist für Mittwoch, den 20. November 2024, um 7:30 Uhr Eastern Time geplant. Interessierte Parteien können über einen Live-Webcast auf die Präsentation zugreifen, und die Wiederholungen sind zwei Wochen lang auf der Investorenwebsite des Unternehmens unter investors.inspiresleep.com verfügbar.
- None.
- None.
MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
Inspire is scheduled to present at 7:30 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When is Inspire Medical Systems (INSP) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Inspire Medical Systems' (INSP) presentation at the Jefferies Conference?
How long will the replay of Inspire Medical Systems' (INSP) Jefferies Conference presentation be available?
What is the focus area of Inspire Medical Systems (INSP) as presented at the Jefferies Conference?
